Diabetes

The Relationship of Flavonoid Intake During Pregnancy With Excess Body Weight and Gestational Diabetes Mellitus

January 3, 2020 Diabetes, Flavonoids, Pregnancy

Consuming Food Rich in Flavonoids Can Reduce Excess Body Weight During Pregnancy

In Summary

A recent study has found that women who consume food rich in flavonoids during pregnancy (found in fruits, vegetation, and also in cannabis, tend to have less excess body weight. European studies have also reported that flavonoid-rich diets during pregnancy can reduce the risk of gestational Diabetes Mellitus (GDM) but their studies recorded women consuming even higher amounts of flavonoids that the women in the American study. A meta-analysis of American and European studies confirms that pregnant women who maintain a flavonoid-rich diet have an easier time managing the excess weight associated with pregnancy.

View this review (yellow link) or download:

The relationship of flavonoid intake during pregnancy with excess body weight and gestational diabetes mellitus Download

The paper is also stored HERE inside the CED Foundation Archive

To explore related information, click the keywords below:

Medical Marijuana Offers Benefits Comparable to Prescription Medication, Without the Side Effects

August 2, 2019 Adult, Adverse Effects, Anti-inflammatory properties, Anxiety, Arthritis, Blood-Levels, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, Case Study, CBD, CED Clinic, CED Foundation, Citizen Science, Depression, Diabetes, DIY, Future Medicine, Impairment, Mental Health, Mood, Muscle Pain, Neuropathy, Pain, Sleep, Social Equity, Stigma, THC

Title: Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses

In a survey of 30 patients using medical cannabis for a range of diseases including rheumatoid arthritis, cancer, hepatitis C, PTSD, among others, patients reported an array of benefits they have reaped from cannabis use. Patients successfully used cannabis in several ways: as an alternative to prescription medication, complementarily with prescription medicine, and to gradually replace use of prescription medication.

Benefits described by participants included the effects of cannabis lasting longer than that of opioids, lower risk of addiction, fewer side-effects. Patients also saw their sleep, anxiety, appetite, and adverse reactions improve with the use of medical cannabis. Larger, more controlled studies may suggest cannabis more affirmatively as an alternative or complementary therapy with prescription medications.

View this review (yellow link) or download:

Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses Download

This paper is also stored here: http://bit.ly/2wqDDdQ inside the CED Foundation Archive

To explore related information, click the keywords below:

5 Frequently Asked Questions About Cannabis

July 31, 2019 Abuse, Addiction, Adverse Effects, Alcohol, Antioxidant, Anxiety, Behavior change, Blood-Levels, Cannabis, Cannabis Dependence, Cannabis Education, Cannabis News, CBD, CED Clinic, CED Foundation, CED In The News, Cognition, Depression, Diabetes, Dosing, Dr Caplan, Future Medicine, Heavy Use, History, Video

Video: Do-It-Yourself Cannabis Tinctures

July 17, 2019 Alcohol, Anti-inflammatory properties, Antibiotic, Antioxidant, Anxiety, Arthritis, Autism, Autoimmunity, Behavior change, Bipolar Disorder, Business of Cannabis, Cannabinoids, Cannabis, Cannabis Education, Cannabis News, Case Study, CBD, CBN, CED Clinic, CED In The News, Cognition, Colon Cancer, Cooking, Cultivation, Cultivation / Growing / Horticulture, Depression, Dermatology / Skin, Diabetes, DIY, Dosing, Dr Caplan, Edibles, Epilepsy, Extraction, Farming, Fibromyalgia, Flavonoids, Future Medicine, Gastrointestinal Effects, Hemp, History, IBS, Insomnia, Male Fertility, Memory, Mental Health, Mood, Muscle Pain, Nausea, Neuropathy, Obesity, OCD, Opiates, Oral Health, Pain, Pediatrics, Processing, Products, Prostate Cancer, Psychosis, PTSD, Schizophrenia, Seizure / Epilepsy, Sleep, Sleep Apnea, Stigma, Stress, Taste, THC, Topical, Video

One of the terrific realities of modern Cannabis is that it is possible, and often quite simple, to make effective products at home. With suitable education and access to testing facilities, the soil, nutrients, and plant growth can be supported at home, lab-tested for make-up and potency, as well as safety-checked for potential microscopic contaminants, and ultimately, individualized medicine can be created right at home!

Here is a sample instructional for just one way that cannabis tincture can be made at home. There are countless others and hopefully, many that are yet to be discovered!

To explore related information, click the keywords below:

Genes in the Endocannabinoid and Opioid Systems may Provide Biomarkers of Obesity

July 16, 2019 Abuse, Anti-inflammatory properties, Antioxidant, Behavior change, Blood-Levels, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Diabetes, Future Medicine, Muscle Pain, Neuropathy, Obesity, Pain, Science, THC

Title: Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity

Researchers have recently found that alterations of the type 1 cannabinoid receptor gene (CNR1) and mu opioid receptor gene (OPRM1) contribute to the development of obesity. This phenomenon was shown in rat models who were given a high-fat diet and humans currently dealing with obesity. Due to the possibility of the up-regulation of CNR1 and OPRM1 providing a mechanism for developing the obesity phenotype, those two genes could serve as biomarkers for obesity. Fortunately, the up-regulation of CNR1 and OPRM1 is reversible and may also provide a target for combatting obesity and encouraging weight loss in obese individuals.

Highlighted here are the interactions of the endocannabinoid and opioid systems. Contradictory evidence concerning the interaction of the two systems has come out in recent years making it difficult to come to any conclusions. The endocannabinoid system has been thought to provide a safe and effective method for combatting the opioid crisis. Opioids are highly addictive and dangerous, but they are an efficient way to minimize pain which has kept them in mainstream medicine. Opioids have led to countless overdoses in recent decades causing researchers to search for a more ethical option for pain relief. Cannabis has a much better safety profile, poses no risk of overdose, and offers a welcome change of pace to traditional choices. Conclusive research is still needed to confirm, and reconfirm the details.

View this review (yellow link) or download:

This paper is also stored here: http://bit.ly/2xOhoPE inside the CED Foundation Archive

Cannabinoids and autoimmune diseases: A systematic review (Diabetes)

July 14, 2019 Animal Model, Anti-inflammatory properties, Autoimmunity, Blood-Levels, CBD, CED Clinic, Diabetes, Dr Caplan, Future Medicine, Placebo-Controlled, Video

As it stands, there is no cure for Type 1 Diabetes Mellitus. But, some of us in the medical community are starting to wonder if cannabis could be a viable treatment option. Several studies already address this, with impressive findings, and now, A new mouse model study suggests that not only could CBD prevent Type 1 Diabetes, but it seems to also reduce symptoms after onset.

Now researchers must determine the long term effects of CBD treatment. Watch a video summary below:

View this review (yellow link) or download:

Cannabinoids and autoimmune diseases: A systematic review Download

This paper is also stored here: http://bit.ly/2Y1paV5 inside the CED Foundation Archive

To explore related information, click the keywords below:

Video: Cannabinoids and autoimmune diseases: A systematic review

July 12, 2019 Anti-inflammatory properties, Arthritis, Cannabinoids, Cannabis Science, Diabetes, Future Medicine, IBS, Science, Video

This literature review summarizes the findings on the role of cannabis in treating autoimmune diseases. Cannabis has anti-inflammatory properties when treating rheumatoid arthritis, scleroderma, type 1 diabetes, IBD, neuropathic pain, and fibromyalgia. Below is a video adaptation of “Cannabinoids in Rheumatoid Arthritis.”

View this review (yellow link) or download:

Cannabinoids and autoimmune diseases: A systematic review Download

This paper is also stored here: http://bit.ly/2Y1paV5 inside the CED Foundation Archive

To explore related information, click the keywords below:

Analyses of Cannabinoid Signaling in the Immune System Highlights Key Questions, Challenges, and Future Directions

June 24, 2019 Adolescents, Anti-inflammatory properties, Arthritis, Autoimmunity, Behavior change, Cannabinoids, Cannabis, Cannabis Science, CB1, CB2, CBD, Depression, Diabetes, Future Medicine, Neuropathy, Pain, Science, THC

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges

A meta-analysis concerning the role of cannabinoid signaling in immune system regulations revealed current therapeutic benefits, challenges for future research, and exciting new directions. Among the current research, cannabinoids have already been found to suppress inflammation associated with autoimmune diseases, especially in multiple sclerosis, rheumatoid arthritis, Type-1 Diabetes, and Crohn’s Disease. Future cannabis-based therapies aim to improve immune responses to organ donation, bone marrow transplants, and skin grafts. The analysis includes challenges facing future cannabis research such as potential side effects and legal status.

View this review (yellow link) or download:

Targeting Cannabinoid Signaling in the Immune System- “High”-ly Exciting Questions, Possibilities, and Challenges Download

This paper is also stored here: http://bit.ly/31ArGR9 inside the CED Foundation Archive

To explore related information, click the keywords below:

Flavonoids May Provide Therapeutic Benefits for Type 2 Diabetes

June 14, 2019 Anti-inflammatory properties, Autoimmunity, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Diabetes, Extraction, Flavonoids, Future Medicine, Non-Cannabis Plant, Placebo-Controlled, Processing, Products, Science

A recent study has found that flavonoids isolated from Psoralea corylifolia are able to inhibit part of the insulin pathway.

Seeds of the P. corylifolia plant have been used in eastern medicine, primary in China, for years, and is now being further researched as flavonoids continue to intrigue researchers with their possible therapeutic benefits. The inhibitory activity found in this study provides evidence that flavonoids should be pursued as a potential treatment for Type-2 Diabetes.

View this review (yellow link) or download:

New compounds from the seeds of Psoralea Corylifolia with their protein tyrosine phosphatase 1B inhibitory activity Download

This paper is also stored here: http://bit.ly/2KORB1v inside the CED Foundation Archive

To explore related information, click the keywords below:

New Extraction Methods for “Polyphenols” Benefits Future Research

June 14, 2019 Anti-inflammatory properties, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, CB1, CB2, CBD, Diabetes, Extraction, Flavonoids, Future Medicine, Obesity, Processing, Science, Terpenes

Citrus peels waste as a source of value-added compounds- extraction and quantification of bioactive polyphenols

A recent study has exposed a more efficient, sustainable, and economically viable extraction method for polyphenols (specific active chemical compounds) from citrus peels. One such polyphenol is Naringin, a flavonoid present in lemon peels, which has been hypothesized to have anti-inflammatory and antioxidant effects, as well as, potentially, to help treat obesity. This new extraction method will allow researchers to discover more definite therapeutic effects of polyphenols in citrus peels.

View this review (yellow link) or download:

Citrus peels waste as a source of value-added compounds- extraction and quantification of bioactive polyphenols Download

This paper is also stored here: http://bit.ly/2F7XrXY inside the CED Foundation Archive

To explore related information, click keywords below: